Myomo, Inc. (NYSEAMERICAN:MYO – Get Free Report) was the recipient of a large increase in short interest in the month of March. As of March 15th, there was short interest totalling 938,500 shares, an increase of 22.3% from the February 28th total of 767,200 shares. Based on an average daily trading volume, of 451,800 shares, the short-interest ratio is currently 2.1 days. Currently, 2.9% of the company’s shares are short sold.
Analyst Upgrades and Downgrades
A number of equities research analysts have weighed in on the company. Alliance Global Partners reiterated a “buy” rating on shares of Myomo in a research note on Tuesday, March 11th. HC Wainwright increased their target price on shares of Myomo from $7.50 to $9.50 and gave the company a “buy” rating in a report on Wednesday, March 12th. Ascendiant Capital Markets boosted their price target on Myomo from $9.00 to $11.00 and gave the stock a “buy” rating in a research note on Monday, March 17th. Finally, Craig Hallum boosted their target price on Myomo from $9.00 to $11.00 and gave the stock a “buy” rating in a research report on Tuesday, March 11th. Five research analysts have rated the stock with a buy rating, According to data from MarketBeat, Myomo presently has a consensus rating of “Buy” and an average price target of $9.75.
Read Our Latest Report on Myomo
Insider Activity at Myomo
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently made changes to their positions in the company. Soleus Capital Management L.P. acquired a new stake in Myomo during the 4th quarter valued at approximately $5,796,000. AIGH Capital Management LLC grew its stake in Myomo by 21.7% in the fourth quarter. AIGH Capital Management LLC now owns 3,381,567 shares of the company’s stock worth $21,777,000 after purchasing an additional 602,719 shares in the last quarter. Portolan Capital Management LLC acquired a new position in Myomo in the fourth quarter worth $2,446,000. Manatuck Hill Partners LLC acquired a new stake in shares of Myomo in the fourth quarter valued at approximately $1,582,000. Finally, Thompson Siegel & Walmsley LLC bought a new stake in shares of Myomo during the fourth quarter valued at approximately $1,288,000. 44.99% of the stock is currently owned by hedge funds and other institutional investors.
Myomo Stock Performance
MYO traded down $0.04 on Wednesday, reaching $4.81. 12,628 shares of the company’s stock were exchanged, compared to its average volume of 335,864. The company has a market cap of $145.50 million, a PE ratio of -20.89 and a beta of 1.68. Myomo has a twelve month low of $2.51 and a twelve month high of $7.17.
About Myomo
Myomo, Inc, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living.
Featured Articles
- Five stocks we like better than Myomo
- What is a SEC Filing?
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- Insider Buying Explained: What Investors Need to Know
- The 3 Most Talked About Investments on WallStreetBets Right Now
- Want to Profit on the Downtrend? Downtrends, Explained.
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for Myomo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Myomo and related companies with MarketBeat.com's FREE daily email newsletter.